Sixth Acquisition Extends Veranex Lead in MedTech Industry Services
Veranex expands global capabilities for human-centered design, innovation, and strategy
Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.
All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.
Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.
Purpose-built solutions. Proven results. User & Patient-centered innovation.
Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity. Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.
We are the Innovation CRO.
Legacy of excellence. Proven execution. Patient impact accelerated.
2 min read
Jessica Casimir : Mar 24, 2025 10:22:43 PM
Most recently Ryan was the Chief Commercial Officer at Sense Biodetection, a venture-backed molecular diagnostics innovator. Prior, he was a Vice President at Edwards Lifesciences’ Critical Care business, CCO at Astute Medical, and V.P. of CareFusion’s (now BD’s) respiratory technologies business.
Veranex’s Chairman & CEO, Pat Donnelly, shared his excitement about the impactful commercial leader joining the team: “All of us here at Veranex could not be more thrilled to have Ryan Roberts join the leadership team.
– Pat Donnelly, Veranex CEO and Chairman
Roberts also shared how eager he is to begin this new journey: “Veranex’s portfolio of conceptualization to commercialization services is unparalleled in the market. I’m enthused about the opportunity we have to accelerate market readiness of meaningful, outcomes-changing technologies for our customers and the caregivers and patients they serve.”
About Veranex
Veranex is the only truly comprehensive, global, tech-enabled service provider dedicated to the medical technology industry. Offering expert guidance from concept through to commercialization and across the development continuum, Veranex enables accelerated speed to market, controlled development costs, development risk mitigation, and accelerated market viability assessment. At every stage, Veranex customers realize efficiencies in cost and time while its integrated and comprehensive solutions unify the entire development process.
Veranex expands global capabilities for human-centered design, innovation, and strategy
Raleigh, NC, December 14, 2023—Veranex, provider of the first purpose-built, global service platform for the medtech industry, today announced that...
1 min read
The addition increases footprint and provides speed, flexibility, and depth of GLP services to North America and the EU. Veranex, the first...